515 related articles for article (PubMed ID: 29164570)
1. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Roldán V; Marín F; García-Herola A; Lip GY
Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
5. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
[TBL] [Abstract][Full Text] [Related]
6. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
[TBL] [Abstract][Full Text] [Related]
7. Correlations of C-reactive protein, von Willebrand factor, and carotid artery intima-media thickness with CHA2DS2-VASc in patients with acute atrial fibrillation.
Rewiuk K; Grodzicki T
Pol Arch Med Wewn; 2015; 125(11):835-44. PubMed ID: 26463558
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
[TBL] [Abstract][Full Text] [Related]
9. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
10. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
11. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.
Lopez-Castaneda S; Valencia-Hernández I; Arean C; Godínez-Hernández D; Viveros-Sandoval ME
Clin Appl Thromb Hemost; 2018 May; 24(4):647-654. PubMed ID: 28618874
[TBL] [Abstract][Full Text] [Related]
13. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
[TBL] [Abstract][Full Text] [Related]
14. Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation.
Freynhofer MK; Bruno V; Jarai R; Gruber S; Höchtl T; Brozovic I; Farhan S; Wojta J; Huber K
Thromb Haemost; 2011 Mar; 105(3):435-43. PubMed ID: 21136020
[TBL] [Abstract][Full Text] [Related]
15. Stroke prediction with CHA
Hu WS; Lin CL
J Clin Neurosci; 2017 Nov; 45():193-198. PubMed ID: 28684149
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
17. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
18. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
19. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
20. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.
Lip GY; Lane D; Van Walraven C; Hart RG
Stroke; 2006 Sep; 37(9):2294-300. PubMed ID: 16888271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
